Bringing science, innovation and collaboration together to overcome barriers in drug development
Arcinova provides contract research, development and manufacturing services that support pharmaceutical and biotechnology companies from early development through to clinical evaluation. Combining scientific expertise with an agile and collaborative approach, we help customers overcome complex development challenges and progress programmes with confidence.
Our mission is to bring science, innovation and collaboration together to overcome the barriers in drug development. We empower emerging biotechs and established pharmaceutical companies alike to advance life-changing therapies through an efficient, quality-driven approach focused on scientific excellence.
Our vision is to advance progress through science, delivering solutions that make a meaningful difference to our customers and the patients they serve.
Drug substance and drug product services from candidate selection to Phase II, and bioanalytical services from preclinical to market
Scientifically unbiased with a focus on understanding customer needs, the molecule, and its developability
A collaborative and consultative approach focused on building strong strategic partnerships
Part of Quotient Sciences.
Built for specialist science.
Arcinova is part of Quotient Sciences, a drug development and manufacturing accelerator supporting pharmaceutical and biotechnology companies worldwide.
We operate as a centre of excellence, providing expertise in drug substance development, aseptic drug product manufacture, bioanalysis and isotope labelling.
Customers can access Arcinova's dedicated teams as a standalone partner or benefit from seamless integration with the broader Quotient Sciences platform, combining deep technical expertise with the flexibility and scale of a wider drug development organisation.
We help programmes progress efficiently from discovery through to clinical evaluation.
